Cargando…

Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels

In order to overcome the limitations associated with vaginal administration of drugs, e.g., the short contact time of the drug form with the mucosa or continuous carrier wash-out, the development of new carriers for gynecological use is necessary. Furthermore, high individual anatomical and physiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Smoleński, Michał, Karolewicz, Bożena, Gołkowska, Anna M., Nartowski, Karol P., Małolepsza-Jarmołowska, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233730/
https://www.ncbi.nlm.nih.gov/pubmed/34208652
http://dx.doi.org/10.3390/ijms22126455
_version_ 1783713916896935936
author Smoleński, Michał
Karolewicz, Bożena
Gołkowska, Anna M.
Nartowski, Karol P.
Małolepsza-Jarmołowska, Katarzyna
author_facet Smoleński, Michał
Karolewicz, Bożena
Gołkowska, Anna M.
Nartowski, Karol P.
Małolepsza-Jarmołowska, Katarzyna
author_sort Smoleński, Michał
collection PubMed
description In order to overcome the limitations associated with vaginal administration of drugs, e.g., the short contact time of the drug form with the mucosa or continuous carrier wash-out, the development of new carriers for gynecological use is necessary. Furthermore, high individual anatomical and physiological variability resulting in unsatisfactory therapeutic efficacy of lipophilic active substances requires application of multicompartment drug delivery systems. This manuscript provides an up-to-date comprehensive review of the literature on emulsion-based vaginal dosage forms (EVDF) including macroemulsions, microemulsions, nanoemulsions, multiple emulsions and self-emulsifying drug delivery systems. The first part of the paper discusses (i) the influence of anatomical-physiological conditions on therapeutic efficacy of drug forms after local and systemic administration, (ii) characterization of EVDF components and the manufacturing techniques of these dosage forms and (iii) methods used to evaluate the physicochemical and pharmaceutical properties of emulsion-based vaginal dosage forms. The second part of the paper presents (iv) the results of biological and in vivo studies as well as (v) clinical evaluation of EVDF safety and therapeutic efficacy across different indications.
format Online
Article
Text
id pubmed-8233730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82337302021-06-27 Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels Smoleński, Michał Karolewicz, Bożena Gołkowska, Anna M. Nartowski, Karol P. Małolepsza-Jarmołowska, Katarzyna Int J Mol Sci Review In order to overcome the limitations associated with vaginal administration of drugs, e.g., the short contact time of the drug form with the mucosa or continuous carrier wash-out, the development of new carriers for gynecological use is necessary. Furthermore, high individual anatomical and physiological variability resulting in unsatisfactory therapeutic efficacy of lipophilic active substances requires application of multicompartment drug delivery systems. This manuscript provides an up-to-date comprehensive review of the literature on emulsion-based vaginal dosage forms (EVDF) including macroemulsions, microemulsions, nanoemulsions, multiple emulsions and self-emulsifying drug delivery systems. The first part of the paper discusses (i) the influence of anatomical-physiological conditions on therapeutic efficacy of drug forms after local and systemic administration, (ii) characterization of EVDF components and the manufacturing techniques of these dosage forms and (iii) methods used to evaluate the physicochemical and pharmaceutical properties of emulsion-based vaginal dosage forms. The second part of the paper presents (iv) the results of biological and in vivo studies as well as (v) clinical evaluation of EVDF safety and therapeutic efficacy across different indications. MDPI 2021-06-16 /pmc/articles/PMC8233730/ /pubmed/34208652 http://dx.doi.org/10.3390/ijms22126455 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Smoleński, Michał
Karolewicz, Bożena
Gołkowska, Anna M.
Nartowski, Karol P.
Małolepsza-Jarmołowska, Katarzyna
Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels
title Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels
title_full Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels
title_fullStr Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels
title_full_unstemmed Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels
title_short Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels
title_sort emulsion-based multicompartment vaginal drug carriers: from nanoemulsions to nanoemulgels
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233730/
https://www.ncbi.nlm.nih.gov/pubmed/34208652
http://dx.doi.org/10.3390/ijms22126455
work_keys_str_mv AT smolenskimichał emulsionbasedmulticompartmentvaginaldrugcarriersfromnanoemulsionstonanoemulgels
AT karolewiczbozena emulsionbasedmulticompartmentvaginaldrugcarriersfromnanoemulsionstonanoemulgels
AT gołkowskaannam emulsionbasedmulticompartmentvaginaldrugcarriersfromnanoemulsionstonanoemulgels
AT nartowskikarolp emulsionbasedmulticompartmentvaginaldrugcarriersfromnanoemulsionstonanoemulgels
AT małolepszajarmołowskakatarzyna emulsionbasedmulticompartmentvaginaldrugcarriersfromnanoemulsionstonanoemulgels